GSK’s market-leading Shingrix vaccine proved effective against shingles more than 10 years post-administration, creating a new hurdle for a number of potential competitors.
READ MOREAfter seven months on the market, Regeneron’s Eylea HD is already making strides with ophthalmologists.
READ MOREA Senate bill that would blacklist Chinese biotech companies like WuXi AppTec from doing business in the US may not see a vote until after the election, if ever. But if it does, the ...
READ MOREJohnson & Johnson and Bristol Myers Squibb are individually gearing up their lentiviral production and CAR-T product capacities following their recent label expansions in multiple ...
READ MORE